Forgot Password?
If you have a user ID already and cannot login, contact Customer Support
You can begin the registration process by clicking here

Innovative research is important to advancing knowledge about our products, core diseases, and therapeutic areas of interest with the goal of advancing patient care. With an electronic process that has been established, we invite qualified and experienced researchers worldwide interested in pursuing their own research concepts to submit their applications through this Investigator Sponsored Study (ISS) Portal for Sanofi/Sanofi Genzyme to review and potentially support.

Please register and/or log in to VisionTracker to view our current Areas of Interest.

We ask that you contact your local Medical Science Liason or Country Affiliate Medical Director before you proceed with your submission, as they can provide you with an overview of the ISS program and its requirements.

In case you do not have a local contact person feel free to send an e-mail to  USISTManagementSys@sanofi.com and clearly indicate:

  • Your contact information and your preferred method of contact
  • Your country of origin
  • Product to be studied or therapeutic area of interest to be studied in your ISS (please register and/or log in to view our Areas of interest)
  • A very brief description of your idea

This information will allow us to forward your inquiry to the appropriate medical affairs personnel in your country or region.


Important Note on Disclosure

Since 2014, U.S. law and regulations have required that pharmaceutical companies collect information relating to payments and other transfers of value to U.S. licensed physicians (wherever they may reside) and U.S. teaching hospitals, and submit the information to the Centers for Medicaid and Medicare Services ("CMS") for publication on its "Open Payments" internet site. Several U.S. States have similar requirements. There are also several companies outside the U.S. that have transparency requirements, including but not limited to France and the United Kingdom. Sanofi is committed to compliance with transparency requirements in the countries in which it does business.